Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis?

Title
Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis?
Authors
Keywords
Adenomatous Polyposis Coli, Circulate Tumor Cell, Clinical Laboratory Improvement Amendment, Single CTCs, Detect Disease Progression
Journal
Genome Medicine
Volume 5, Issue 8, Pages -
Publisher
Springer Nature
Online
2013-08-13
DOI
10.1186/gm474

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started